Recombinant multi-species SP140 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SP140 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the SP100 family of proteins, which are share common domains including an N-terminal homogeneously staining region domain followed by a SP100/autoimmune regulator/NucP41/P75/deformed epidermal autoregulatory factor domain, a plant homeobox zinc finger, and a bromodomain. The encoded protein is interferon-inducible and is expressed at high levels in the nuclei of leukocytes. Variants of this gene have been associated with multiple sclerosis, Crohn's disease, and chronic lymphocytic leukemia. Alternative splicing results in multiple variants. [provided by RefSeq, Aug 2016]
The Alternative Names of target: LYSP100,LYSP100-A,LYSP100-B,Lymphoid-restricted homolog of Sp100 (LYSp100),Nuclear autoantigen Sp-140,Nuclear body protein SP140,SP140,SP140L,Speckled 140 kDa
Go
to SP140 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP4082-Ag-1/ GM-Tg-hg-IP4082-Ag-2 | Human SP140 protein | Human |
| GM-Tg-rg-IP4082-Ag-1/ GM-Tg-rg-IP4082-Ag-2 | Rat SP140 protein | Rat |
| GM-Tg-mg-IP4082-Ag-1/ GM-Tg-mg-IP4082-Ag-2 | Mouse SP140 protein | Mouse |
| GM-Tg-cynog-IP4082-Ag-1/ GM-Tg-cynog-IP4082-Ag-2 | Cynomolgus/Rhesus macaque SP140 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP4082-Ag-1/ GM-Tg-felg-IP4082-Ag-2 | Feline SP140 protein | Feline |
| GM-Tg-cang-IP4082-Ag-1/ GM-Tg-cang-IP4082-Ag-2 | Canine SP140 protein | Canine |
| GM-Tg-bovg-IP4082-Ag-1/ GM-Tg-bovg-IP4082-Ag-2 | Bovine SP140 protein | Bovine |
| GM-Tg-equg-IP4082-Ag-1/ GM-Tg-equg-IP4082-Ag-2 | Equine SP140 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP4082-Ag-1/ GM-Tg-hg-IP4082-Ag-2;
GM-Tg-rg-IP4082-Ag-1/ GM-Tg-rg-IP4082-Ag-2;
GM-Tg-mg-IP4082-Ag-1/ GM-Tg-mg-IP4082-Ag-2; GM-Tg-cynog-IP4082-Ag-1/ GM-Tg-cynog-IP4082-Ag-2; GM-Tg-felg-IP4082-Ag-1/ GM-Tg-felg-IP4082-Ag-2; GM-Tg-cang-IP4082-Ag-1/ GM-Tg-cang-IP4082-Ag-2; GM-Tg-bovg-IP4082-Ag-1/ GM-Tg-bovg-IP4082-Ag-2; GM-Tg-equg-IP4082-Ag-1/ GM-Tg-equg-IP4082-Ag-2 |
| Products Name | SP140 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | SP140 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine SP140 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.